Societal CDMO Inc
F:RAH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tata Elxsi Ltd
NSE:TATAELXSI
|
IN |
|
Evergrande Property Services Group Ltd
HKEX:6666
|
CN |
|
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
US |
|
K
|
Kojamo Oyj
OMXH:KOJAMO
|
FI |
Societal CDMO Inc
Cash from Operating Activities
Societal CDMO Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Societal CDMO Inc
F:RAH
|
Cash from Operating Activities
-$1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
53%
|
CAGR 10-Years
-2%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Operating Activities
$24.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Operating Activities
$14.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
21%
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Operating Activities
$11.7B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Operating Activities
$16.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Operating Activities
$16.8B
|
CAGR 3-Years
30%
|
CAGR 5-Years
21%
|
CAGR 10-Years
19%
|
|
Societal CDMO Inc
Glance View
Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The company is headquartered in Exton, Pennsylvania and currently employs 258 full-time employees. The company went IPO on 2014-03-07. Societal CDMO is principally focused on solving various manufacturing problems. The company is a CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. In addition to its experience in handling Drug Enforcement Agency (DEA) controlled substances and developing and manufacturing modified-release dosage forms, the Company has the ability to deliver on its clients pharmaceutical development and manufacturing projects. The company conducts its operations in Gainesville, Georgia and San Diego, California.
See Also
What is Societal CDMO Inc's Cash from Operating Activities?
Cash from Operating Activities
-1m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Cash from Operating Activities amounts to -1m USD.
What is Societal CDMO Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-2%
Over the last year, the Cash from Operating Activities growth was 72%.
